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ABSTRACT
Background: D-b-Aspartic acid residues, which are
biologically uncommon, have been reported to accumulate
in various proteins of the living body with age. In the
present study, D-b-aspartic acid-containing proteins were
found to be localised in pingueculae, which represent one
of the most prominent age-related ocular changes.
Methods: Surgical specimens of conjunctivae with or
without pingueculae were obtained from eight patients.
Immunohistochemical localisation of D-b-aspartic
acid-containing proteins was performed using a poly-
clonal antibody against D-b-aspartic acid-containing
peptides.
Results: Strong immunoreactivity to D-b-aspartic acid-
containing peptides was detected in the subepithelial
amorphous materials of all surgical specimens with
pingueculae. In contrast, no immunoreactivity to D-b-
aspartic acid-containing peptides was detected in the
specimens without pingueculae.
Conclusions: Pingueculae are thought to be aggregates
of proteins that contain D-b-aspartic acid residues. It is
known that the conversion of L- to D-aspartyl residues is
accelerated by ultraviolet irradiation. In addition, D-b-
aspartic acid-containing proteins, in general, tend to
aggregate with each other and accumulate in the tissues.
These facts indicate that ultraviolet irradiation-induced
racemisation of aspartic acid is closely related to the
development of pingueculae.
The ageing process is known to be related to
various ocular lesions and diseases, including
pingueculae. Epidemiological studies have revealed
that ultraviolet irradiation as well as the ageing
process is involved in the development of pingue-
culae.1 However, the pathogenesis of these lesions
remains unclear. Recently, racemisation of amino
acids and the resultant D-amino acids in proteins
have been studied as biochemical markers of the
ageing process.2–7 It was previously believed that
living organisms contained only L-amino acids and
that organisms containing D-amino acids had
become extinct. However, D-amino acids have
been found in proteins obtained from the lenses,2–
5 7–11 drusen,7 teeth,12 bones,13 brains,14 skin,6 aor-
tas,15 erythrocytes,16 lungs17 and ligaments18 of
elderly people. These D-amino acids in proteins
are considered to be derived from the racemisation
of L-amino acids in various tissues at body
temperature. Thus, D-amino acids in the proteins
of living organisms are considered to be markers of
the ageing process.
In the present study, we investigated the
immunohistochemical localisation of D-b-aspartic
acid-containing proteins in surgical specimens with
and without pingueculae.
MATERIALS AND METHODS
Surgical specimens of conjunctivae with or without
pingueculae
In the present study, informed consent was
obtained from all patients who were undergoing
surgery. To investigate the pathogenesis of pingue-
culae, the immunohistochemical localisation of D-
b-aspartic acid-containing peptides in surgical
specimens with and without pingueculae was
performed. A total of eight pingueculae from eight
patients (four men and four women; ages, 57.1 (SD
13.0) years) were excised. As controls, specimens of
conjunctivae that did not contain pingueculae
were obtained from the temporal or nasal part of
the cornea; the specimens were excised during
strabismus surgery and then analysed (four men
and four women; ages, 59.4 (11.3) years). All men
were outdoor workers, and the women were
housewives or indoor workers. Haematoxylin–
eosin staining and immunohistochemistry were
performed on all surgical specimens.
Antibody against D-b-aspartic acid-containing
peptides
The preparation and characterisation of a poly-
clonal antibody against D-b-aspartic acid-contain-
ing peptides have been previously described.5 6 10 19
In brief, a polyclonal antibody against the peptide
Gly-Leu-D-b-Asp-Ala-Thr-Gly-Leu-D-b-Asp-Ala-Thr-
Gly-Leu-D-b-Asp-Ala-Thr, designated peptide 3R,
was prepared and purified. This peptide corresponds
to three repeats of the residues at positions 149–153
of human a-A-crystalline. The antibody clearly
distinguished between aspartic acid residues of
different configurations; that is, it reacted strongly
with the D-b-aspartic acid-containing peptides
but did not react with the L-a-Asp-, L-b-Asp- or
D-a-Asp-containing peptides.
Immunohistochemistry
D-b-Aspartic acid was immunohistochemically
localised in the surgical specimens of conjunctivae
with or without pingueculae. In brief, 4-mm-thick
formalin-fixed paraffin-embedded sections were
prepared. After deparaffinisation, the sections were
treated with a polyclonal antibody (dilution, 1:500)
against D-b-aspartic acid-containing peptides; the
antibody was dissolved in phosphate-buffered
saline (PBS) containing 1% bovine serum albumin,
and the sections were maintained overnight at 4uC.
After the sections were washed with PBS, they
were treated with a reaction solution containing
the secondary antibody labelled with an amino
acid polymer and horseradish peroxidase (Histofine
Max-PO kit; Nichirei Co., Tokyo) and maintained
at room temperature for 30 min. The sections were
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then washed with PBS again and incubated with diaminoben-
zidine (DAB) in PBS. Finally, the sections were counterstained
with haematoxylin.
An absorption test was used to show the specific affinity of
the antibody for D-b-aspartic acid-containing peptides. In brief,
instead of using the polyclonal antibody to D-b-aspartic acid-
containing peptides, a mixture of the polyclonal antibody
(dilution 1:500) and peptide 3R (final concentration 1 mg/ml)
was used for immunohistochemistry.
As a negative control, the primary antibody was replaced
with normal rabbit serum immunoglobulin (Ig)G (1.0 mg/ml)
diluted with PBS containing 1% bovine serum albumin. After
these preparatory steps, the sections were processed for
immunohistochemistry as described above.
RESULTS
Figure 1 shows the typical features observed on haematoxylin–
eosin and immunohistochemical staining of conjunctival speci-
mens obtained from donors in their 50 s. In the specimens with
pingueculae, eosinophilic and amorphous materials were
detected in the subepithelial layer of the conjunctiva (fig 1A).
Strong immunoreactivity to D-b-aspartic acid-containing pro-
teins was detected in the amorphous materials in the
subepithelial layer of the samples with pingueculae (fig 1B).
After the absorption test, the immunoreactivity to D-b-aspartic
acid was greatly reduced in the conjunctival specimens contain-
ing pingueculae (fig 1C). In the negative controls, non-specific
immunoreactivity was not detected in the subepithelial layer of
the surgical specimens with pingueculae (data not shown).
Further, eosinophilic and amorphous materials were not
detected in the subepithelial layer of the surgical specimens
without pingueculae. No immunoreactivity to D-b-aspartic acid
was observed in the control conjunctivae (fig 1D), the
conjunctival specimens after the absorption test (data not
shown) or the negative controls (data not shown).
DISCUSSION
The purpose of the present study is to reveal role of D-b-aspartic
acid-containing proteins in the development of pingueculae.
Previous studies have shown that pingueculae are aggregations
of hyaline materials and arise because of elastotic degenera-
tion.20 21 However, the concept of hyalinisation or degeneration
is too vague to explain the exact nature and pathogenesis of
pingueculae. Recently, it has been reported that pingueculae
contain advanced glycation end products (AGEs) such as Ne-
(carboxymethyl)-L-lysine, pentosidine, imidazolone and pyrra-
line.22 We demonstrated for the first time, to the best of our
knowledge, that pingueculae are accumulations of D-b-aspartic
acid-containing proteins. The appearance of these proteins is
likely to induce a major change in the higher-order protein
structure because D-aspartic acid residues are oriented against
the direction of the peptide plane. In addition to the formation
of D-aspartic acid residues, beta-linkage of these residues affects
the quaternary structure of proteins because the main chain of the
proteins is elongated. Thus, these uncommon configurations of
aspartic acid are considered to be one of triggers for the abnormal
aggregation of proteins. D-b-Aspartic acid in proteins is formed via
a succinimide intermediate, as described in our previous papers.3
Racemisation was previously shown to rapidly proceed when the
carboxyl side group of the aspartic acid residue is small, such as
glycine, alanine and serine; in this case, L- aspartic acid residues of
proteins are easily converted to D-aspartic acid residues under
physiological conditions. For this reason, D-amino acids are
regarded as one of the biological markers of the ageing
process.3 6 9 12 15 18 In fact, we have found that D-b-aspartic acid
tends to accumulate with age in various ocular tissues, including
Figure 1 Immunohistochemical localisation of D-b-aspartic acid in pingueculae. Eosinophilic amorphous materials were detected in the subepithelial
layer of the conjunctiva in specimens with pingueculae (A). Strong immunoreactivity to D-b-aspartic acid is seen in the subepithelial amorphous
materials (B). No immunoreactivity to D-b-aspartic acid is seen in specimens after the absorption test (C). No immunoreactivity to D-b-aspartic acid is
seen in surgical specimens without pingueculae (D). Bar = 100 mm.
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the lens, sclera, lamina cribrosa, Bruch membrane, inner limiting
membrane, basement membrane of non-pigment ciliary epithelial
cells and drusen.7 These results indicate that racemisation and the
resultant D-amino acids are involved in the aggregation of
proteins, which leads to the appearance of age-related changes
in the eyes. The results of the present study show that
pingueculae are aggregations of D-b-aspartic acid-containing
proteins, and this finding supports the hypothesis that D-amino
acids are biological markers of the ageing process.
Both the present and recent studies have shown that
pingueculae are aggregations of proteins containing D-amino
acids and AGEs, both of which are similar in various aspects. First,
ultraviolet irradiation accelerates the formation of both D-amino
acids and AGEs.6 19 23 Second, D-amino acids and AGEs tend to
accumulate in the body with age.3 6 9 12 15 18 23 Third, the molecular
structure and the function of proteins are altered because of D-
amino acid and AGE formation.24 25 For these reasons, D-amino
acids and AGEs are regarded not only as markers but also as the
molecular basis of the ageing process. Furthermore, AGE
formation is known to accelerate the racemisation of amino
acids. These facts indicate that the accumulation of D-b-aspartic
acid in pingueculae is accelerated not only by topical irradiation by
ultraviolet rays but also by the formation of AGEs.
Diabetes is known to accelerate AGE formation in tissues,
including corneal epithelial cells, endothelial cells and the base-
ment membrane of the cornea. Neither AGEs nor D-b-aspartic
acid was observed in the conjunctival cells of non-diabetic
patients. However, the localisation of AGEs and D-b-aspartic acid
in patients with diabetes was not assessed. Further studies are
required to reveal the role of AGEs and D-b-aspartic in diabetes.
The racemisation of amino acids in proteins progresses very
slowly, with a half-life of thousands of years. This means that
aggregation of D-b-aspartic acid-containing proteins in pingue-
culae cannot be attributed to a low turnover rate of
subconjunctival tissue. Some molecular mechanisms must
underlie the development of pingueculae and involve the
acceleration of the racemisation of amino acids in proteins.
Pingueculae themselves do not deteriorate visual acuity; they
are primarily cosmetic problems. The molecular mechanism
underlying the development of pingueculae would facilitate
further understanding the ageing process of various organs.
Further studies that aim to reveal the role of D-amino acids in
the ocular and systemic ageing process are ongoing.
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